1/19
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
What is the difference between tumor specific vs associated antigens
Tumor-specific antigens,
only on tumor cells
Mutated host proteins
(e.g., HIV, HTLV, EBV, KSHV, HPV)
Tumor-associated antigens
found on both normal and tumor cells
Describe CD4/8 roles in Tumor response
Describe the problem w/ CD8
CD4/8 roles
CD4 T Cells Role in Tumor Immune Responses
produce cytokines -> effective CTL generation
TNFa and IFNy -> increases MHCI expression on tumor cells
CD8+ T lymphocyte Role
surveillance + kill tumor cells
Problem w/ CD8 roles:
Lack of costimulation to initiate response
Cross-presentation of internalized tumor antigens by APCs (DCs)
MHC class II presentation
CD4+ cell help
B7.1(CD80), B7.2 (CD86)
Cytokines listed above
[REVIEW] Lymphocyte Recognition of Transformed Cells

Describe the role of NK cells in tumor suppression
Natural Killer (NK) cells
Can Kill b/c tumor cells can have LOWERED MHC-1 expression

Describe methods (5) of Immune Evasion by Tumor Cell
Low immunogenicity:
NO peptide:MHC ligand
No Adhesion Molecules
No Costim. Molecules
Tumor treated as self antigens:
Antigenic modulation:
Ab binds to tumor cell -> cell endocytose + degrade
Tumor induced Immune suppression:
Secrete Factors (TGF-B) -> inhibit T cells
Induction of Treg cells via tumors
Tumor induced privileged site:
Secrete factors -> physical barrier
List the two types of Therapy Against Tumors
Drugs that kill dividing cells or block cell division.
(hair loss, gut inflammation, immune suppression, blood clots, liver/kidney dysfunction)
immunotherapy: tumor-specific.
Augment weak host immune response
(active immunotherapy).
Admin of tumor-specific antibodies and/or T cells
(passive immunotherapy)
List the Different forms of immunotherapy
Stem cell transplants (bone marrow transplants)
Active immunization with tumor vaccines
Adoptive immunotherapy by adoptive transfer of tumor specific-T cells
Passive immunotherapy w/ anti-tumor antibody infusions.
Strong adjuvants coupled w/ tumor peptides
Vaccination against oncogenic viruses
Transfection of tumor cells w/ costimulatory molecule genes or cytokine genes and re-infusion.
CAR T cells
Bispecific antibodies
Describe immunotherapy using Abs
What is it?
Problem/Solution
Therapy With Antibodies
What is it?
Abs against tumor antigens
(initially called “magic bullets”)
Effector fxn similar
Opsonization
Phagocytosis
Activation of complement
Problem:
Increased mutations of tumor antigens.
Possible sln: antibody cocktails
Alt. strat:
Abs coupled to immunotoxins -> delivery of cytotoxic agents specifically to tumor cells
EX: ricin, diphtheria toxin


What is Check Point Blockade? Via?
Check Point Blockade
Use of monoclonal abs -> block inhibitory signaling
Via CTLA-4* or PD-1 * on T cells
NOTE:
Immune checkpoint pathways are in addition to Signal 1 & Signal 2
Several different receptors on T cells, and ligands on APC or tumor cells fine tune the immune response by enhancing T cell activation or increasing T cell inhibition (immune checkpoints).
What is the method that won the 2018 Nobel Prize in Physiology or Medicine

Describe how Bi-specific Antibodies work?
Bi-specific Antibodies
Method:
Abs has two arms
One grabs myeloma cell
Other directly engage a key immune cell (NK/T)
The NK/T cells destroy cancer
NOTE:
This unique approach is really a combination of two strategies at the same time:
1. A monoclonal antibody that targets myeloma cells and induces the immune system to destroy the myeloma cell – sometimes called “humoral” immunity.
2. A monoclonal antibody that engages a local immune cell to directly kill the myeloma cell – sometimes called “cellular” immunity
Describe Cellular Therapy method

Describe Hematopoietic Stem Cell Transplant
Two Types
Method
Hematopoietic Stem Cell Transplant
Two Types:
Autologous
CD34+ hematopoietic stem from pt. Bone marrow
Allogenic:
CD34+ hematopoietic stem from donor
Method:
Stem cells collected/ cryopreserved
Chemo therapy -> kills immune cells in bone marrow
melphalan or other drug(s
Admin 1-2 days prior to stem cell infusion
Stem cell infusion
new stem cells replace the cells that the chemotherapy destroyed
Describe Chimeric T Cell Receptor (CAR-T)
Method
T cells isolated from patient blood
given lentiviral vector expressing CD19 directed chimeric T cell receptor (CAR)
T cells w/ Car infused back into pt.
Now T cell have kill capabilities and recognition capabilities

Describe one way we can use CRISPR/Cas9 Technology to combat cancer

Describe Augmentation of Immunity by Cytokines and Costimulators
Problem
Sln
Potential cytokines?
Problem:
B cell origin tumor cells lacks costimulatory and MHC class II molecules.
Sln:
Vaccination w/ tumor cells transfected w/ B7 molecules -> protective immunity against unmodified tumor cells.
Various types of potential Cytokine expression vectors:
IL-2 and IL-12
(stimulates NK and CTL activity).
GM-CSF
(rejection or regression of tumor growth).
IFN
(increases cytolytic activity of NK cells and expression of MHC class I molecules on tumor cells)
Describe Therapeutic Vaccination with Tumor Cells or Tumor Antigen
Good vaccine candidates
Procedure
Good vaccine candidates:
Peptides recognized by tumor-specific CTLs
Procedure:
Administration of peptides with adjuvants.
Use of APCs (dendritic cells):
Pulsing APCs in vitro with peptide prior to administration
Transfection with genes that encode these peptides -> class I presentation.



